Peer Review History
| Original SubmissionApril 27, 2023 |
|---|
|
PONE-D-23-12780Evaluation of the hoof centre-of-pressure path in horses affected by chronic osteoarthritic painPLOS ONE Dear Dr. Buser, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please review your article in light of the comments provided by the reviewers. I am particularly interested on your thoughts regarding diagnosis and absence of a control group. The reviewers have provided many suggestions and I am sure you will find them useful. Please submit your revised manuscript by Jul 20 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Aliah Faisal Shaheen Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service. Whilst you may use any professional scientific editing service of your choice, PLOS has partnered with both American Journal Experts (AJE) and Editage to provide discounted services to PLOS authors. Both organizations have experience helping authors meet PLOS guidelines and can provide language editing, translation, manuscript formatting, and figure formatting to ensure your manuscript meets our submission guidelines. To take advantage of our partnership with AJE, visit the AJE website (http://learn.aje.com/plos/) for a 15% discount off AJE services. To take advantage of our partnership with Editage, visit the Editage website (www.editage.com) and enter referral code PLOSEDIT for a 15% discount off Editage services. If the PLOS editorial team finds any language issues in text that either AJE or Editage has edited, the service provider will re-edit the text for free. Upon resubmission, please provide the following: The name of the colleague or the details of the professional service that edited your manuscript A copy of your manuscript showing your changes by either highlighting them or using track changes (uploaded as a *supporting information* file) A clean copy of the edited manuscript (uploaded as the new *manuscript* file)” 3. Please make sure that all information entered in the 'Ethics Statement' section regarding ethics approval is also included in the Methods section of the manuscript 4. Thank you for stating the following financial disclosure: “The present study was part of a larger trial evaluating the efficacy of a novel analgesic treatment in horses, which was funded by a Spark SNSF grant (CRSK-3_190256, received by CS; https://www.snf.ch/de) and by a grant from the ANALGESIA Institute Foundation and the DOMES PHARMA Group (https://www.domespharma.com/en/home/ received by CS). “ Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 5. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. 6. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. Additional Editor Comments: The reviewers have submitted thorough commentaries and suggestions for your article that I hope you find useful. Please provide a point-by-point response with any changes made to the manuscript. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The manuscript presents an interesting study on hoof centre of pressure path in chronically lame horses. The number of included horses is relatively large for this type of study, and the study group is well defined. A limitation is that no control group with healthy horses is included. Another limitation is that it was not confirmed that the included horses were only affected in one limb at the time of measurement, since no diagnostic algesia was performed to confirm the localization of pain. This needs to be considered especially given that several horses had a history suggestive of multi-limb lameness. Another limitation is that, to my knowledge and according to the information presented in the manuscript, the measurement equipment used has never been validated against any kind of gold standard, for example force plate data, which means that the level of measurement errors is unknown. Even with these limitations, the study is still interesting since there is limited data available on this topic. However, there are a number of unclarities regarding how the data were analyzed that need to be addressed, and it is possible that some parts of the statistics need to be redone, please see my comments below. Page 8 Line 26. Unclear what this meant by objective lameness examination in this context. Line 34. What is the meaning of the ending s in COPps? Plural? Page 9 Line 57. Unclear what you mean by indices (which is also spelled incorrectly here). Line 63.”To date; no study has addressed the course of COPp in a population of horses with altered weight bearing due to pain.” This is incorrect. You have missed you include the following study in your reference list: Evaluation of an in-shoe pressure measurement system in horses 10.2460/ajvr.2001.62.23 Page 10 Line 71. “calculate shape indices for the average COPp at walk and trot” Again unclear what you mean by indices. Page 12 Table 1. Note that the PLOS formatting guide instructs that the table legends should appear above and not below the table. This applies to all tables. Line 107. “foreseen for the analgesia trial” Odd wording. Rephrase? Line 123. Please provide details on the calibration procedures used for the sensors. With this type of pressure sensor, frequent calibration is crucial to obtaining correct results. Page 13 Line 126. Please specify exactly how you determined which limb that was considered lame and sound, including how you combined the subjective and objective scores. Line 128. Not sure what you mean by custom made. Did you write your own software for this purpose? Or was this proprietary software that came with the measurement equipment? Line 132. Does this mean that a minimum of 20 strides total were collected for each horse in walk but only 10 trot strides? Why? Line 137. Here you say 501 points but under data analysis it says 101 points. Am I missing something? Line 138. Why did you want to make this comparison? Also, the results for this comparison are not reported anywhere. Line 141. It’s not obvious why this normalization process was undertaken, given that normalization is inherent to the Procrustes algorithm. Was this for calculating the shape indices that you describe further below? Please specify for which analysis/analyses that these normalized data were used. Page 14 Line 153. I interpret this that you are comparing strides that come from the same horse, hoof and gait. In that case, why was it relevant to use Procrustes for this? No scaling, translation or rotation should be necessary to compare the center of pressure paths in that case, unless the sensor position relative to the hoof was unstable. If that was not the case a simple root mean square difference should give you the same result. That is, you can apply the formula for calculating the D-value directly to the data without transforming it first. Please explain the rationale for using this analysis. Further, when comparing multiple measurements it is more appropriate to use generalized Procrustes analysis, which the Matlab function that you have used doesn’t do. Please explain why you chose this approach. Find 155. What did you input as target shape and comparison shape to the matlab procrustes function, respectively? Note that D-values returned from this function are normalized to the target shape. Please report this both for comparing strides from the same trial/hoof, and for comparing sound and lame limbs. Also, since it is known that chronic lameness can influence hoof shape over time, is it possible that this has confounded the D-values when comparing sound and lame limbs? Figure 1. The hoof print in this figure looks weirdly distorted, it seems that the width/height relationship is off. Also, please capitalize Cm in the same way you have done in table 2 and please indicate the unit of the X and Y axes. Line 163. I assume this should be table 2 rather than table 3? Page 15 Table 2. Isn’t Cm also illustrated in Figure 1? Line 172. Please specify how footstrike and lift-off events were defined and determined. Page 16 Line 189. “were initially analysed for all 17 horses together and subsequently as independent variables” I don’t understand this part of the sentence. From reading the next sentences I assume this means that you made a group-level analysis ignoring that each horse has two limbs, and then a pairwise analysis taking this fact into account. I don’t quite understand why the first type of analysis makes sense in this context though, see my following comment. Line 190. The Mann Whitney U doesn’t take repeated measures into account. This means that this analysis can’t be used for this dataset since each horse contributes one value for the left and one value for the right limb (minimum, more if you don’t use a summary measure per limb). I suggest that you use a repeated measures ANOVA or a mixed model, that includes horse and limb nested in horse as random variables (assuming stride-by-stride data) and transform the outcome variable as needed to achieve normal distribution of the residuals. Line 191. “To characterise the behaviour of the single-strides COPp and the resulting D-values in individual horses, a subject-based analysis was performed using the Wilcoxon Signed Rank test to compare limbs for each gait.” I’m not entirely sure what you have done here. From my perspective it makes the most sense to compare sound and lame limbs within each horse and across all horses, using a summary measure, e.g. the median D-value, for each horse and hoof. From the legend for figure 4 it seems that you have indeed done this. However, you have failed to describe what summary measure you used. From the results text, it seems that you have also applied this analysis on an individual level. That’s not exactly great since the sample size will depend on the number of strides recorded, and since consecutive strides hardly can be considered independent measures, which is an underlying assumption of the statistic. Line 195. You might want to be consistent with how the signed rank test is capitalized or not. Compare this and the previous sentence. Page 18 Tables 3 and 4. I don’t understand how this is two tables. It would make more sense to make them table 3 A and B if you want to have a separate annotation for each panel. Line 224 cont. This statistical evaluation is not described in the statistics section. Please describe how this test was applied and what statistic that was used. Page 19 Table 5. The table contains unexplained abbreviations. You may want to refer to table 3 for this. “From left to right: shape indices for lame and sound limbs deriving from the first walk trial (WALK1), from the second walk trial (WALK2) and from the trot trial (TROT).” Is there a specific reason why the two walk trials are reported separately in this table but not otherwise? Supporting information. The Excel document contains one sheet with D-values, however, it isn’t specified to which horse each value belongs. Further, since there are a lot of missing values in the end of some columns but never further up, it seems that all values on the same row do not belong to the same horse. This means that these data can’t be used to reproduce your statistics. Please update this sheet to include horse information. Reference list. A few of the references are in correctly formatted or like information, e.g. name of the journal, e.g. nr 3 and 28. Reviewer #2: This paper seeks to look at COP in horses with chronic OA. Title: if definitive localization of the lameness via nerve or joint blocks was not performed the title has to change to just indicate lameness and not lameness due to chronic oa. General Abstract Comments: ideally indicate the number each of fore and hind limb lamenesses and their sites. Are these bilateral lamenesses (as chronic oa tends to be)? Aka the “sound” side may still be affected. How were they diagnosed as chronic OA? I am a little concerned about lumping different lameness and sites and front and hind limbs together. Line 42- is the lateral footstrike on all limbs or only the lame ones? 40-41- p values? Quantification of the difference? Statistical tests used? 44 by typical do you mean unique to each horse? Typical makes it sounds as if all horses have the same response, which the second part of that sentence doesn’t support. Highly repetitive within a horse correct? INTRODUCTION 60. could you clarify this phrase? Is consistency the best word? What is this in relation to? Objective lameness evaluation? Only COP measurement? Do you have concerns about achieving this in lame horses? 66 would single stride data be more variable and not as representative as averaging several strides? How do you “pick” the stride? Potential bias from that process- please justify further 74- please add into the intro the literature from which you based your hypothesis that the COPp would be more consistent in lame horses. 77 difference between front and hind limbs? Sound and lame limbs? Limbs on different horses? 79 do you mean objective lameness severity? Positively or negatively correlate? Please clarify METHODS 91- radiographic presence of OA does not necessarily correlate to clinical lameness. Were these horses blocked (nerve or IA) to prove that the OA was the source of the lameness vs. soft tissue origin? How was the site of lameness localized? Without this information, you can state you studied COP in lame legs, but I don’t think you can positively state that it was chronic OA related. This may require a title change subsequently. 95 many of these horses are retired, how can you then use inclusion criteria of decreased performance or intolerance to being ridden? Table 1- subjective lameness grade should be referenced and explained. Was there a inclusion criteria for subjective lameness? Table 1- I appreciate your indicating bilateral or not for affected limbs, how did you assess the issue with the other limb? Did you compare COP’s to the other potentially affected limb in these instance or? Aka what did you use for “sound” comparisons? How did you decide you could pool together front and hind limbs? GRF in front vs hind limbs are different and COPs likely will reflect this too. Is there a refernce which has pooled front and hind together before validating this? Who assessed the subjective lameness? One person? Many? Intraclass correlations for that if many? Can you describe how they were assessed? Footing? Circles? Etc? at the same farm or ? What are the qualifications of the vet/s who diagnosed them? 97- corticosteroids can have anti-inflammatory effects that last longer than 4 weeks- if pain returns, it is suggestive of a soft tissue component to the issue or a misdiagnosis of the joint that is painful, please discuss/explain 99 was blood used to look for other medical issues? Clarify please if this related to part of your exclusion of other medical issues indicated in the first part of the sentence. As it is written now it sounds as if it is something else and not for that reason. 100 17 horses out of how many? How were they located? Previous clients? Elicited via an email for the research? 106- qualifications? One vet only? 107 foreseen is not the correct word here, maybe just delete? 109 may be an aberrant | after lameness? I’d like to see this paragraph above the table as this explains the subjective lameness grades. I think there should be an exclusion on the high end of the lameness scale for this study, no? 119 Do you have references that you can cite that indicate that if bilateral lameness is present that the Xsens will always pick up on it in horses that aren’t blocked? According to Keegan et al. AJVR 2012 “By contrast, the inertial sensor system measures the asymmetry of head movement between the right and left portions of a stride. Horses with bilateral forelimb lameness, in which the severity of lameness in opposite limbs is equivalent in every stride, would be judged as symmetric if inertial sensors were used…but the inertial sensor system cannot measure the absolute severity of lameness in 1 limb in any 1 stride.” So that the inertial sensors can pick out the lamer of paired legs only. This needs to be further detailed/justified/supported if you are claiming that the opposite leg serves as a control based on xsens inertial sensor data. Also how did, or did you address/recognize compensatory lameness? 119- I don’t know if this journal allows you to refer to items by brand names (equigait) 126 bilateral lameness, especially when there is evidence for it in the history, ideally would have had see the horse’s lamest leg blocked to show that the opposite leg didn’t become sore. 131 what did you do to target a constant speed? Did you have markers set up to measure acceleration or deceleration? 191-193 what did you do to correct for multiple comparisons? 204 have you looked at front alone and hind alone? I am leary of pooling front and hind together, or would like to see the numbers and stats that you have to demonstrate they are ok to be pooled. 214 please clarify significant and trend? Trend normally indicates a non significant finding so these appear contradictory. Table 3 and 4, are these corrected p values in any way for the number of comparisons indicated? Also this is confusing as the p value looks to be just looking at within a horse between the lame and sound leg? But I think you compared just overall lame to sound? Are some of these p values repeated as WIlcoxin should take into account all lame vs all sound. Some of these p values may reflect type 1 errors and become non significant if adjusted for the number of tests. Table 6 define Q, clarify division by left right, include N=17 describe how this related to lateral sidedness. 230 p values ofter just go to one or 2 digits beyone the . sometimes you are 2 and other times 3, please see journal conventions DISCUSSION 246-250 this is too intro like, please address whether you accept, partially accept or reject your specific hypotheses briefly and concisely, then go into details comparing to lit in later paragraphs. Paragraph 255 too intro and method like, need to compare your results to the literature as the focus. 269 decreases in variability… is higher…. Is unclear. Please clarify 277 phenotyped how? I’m still uncomfortable claiming the pain is definitively OA pain, need to mention different joints can express things differently in the limitations if not here more explicitly 278 at the individual what? I would like to see statistics behind this claim that it wouldn’t affect things. I particularly need to see data of front vs hind, to understand if they can legitimately be pooled. 280- lack of diagnostic analgesia to localize the lameness should be explicit earlier and in the limitations. Given this information, I think you have to rephrase the paper in light of lameness and not chronic oa. You can include in the chart areas of previous concern from oa, and should include historical data of the length of lameness in the leg (over the short and long term). 305-306 too method like, delete 308 this is somehow not surprising, is not clear please rephrase 315 I dislike tendency, if this was NOT statistically significant it should not be discussed as if it is, please remove and just say this wasn’t significantly clear in this study but previous studies found…. 328 Nauwelarts didn’t observe this study please rephrase, just say Similar to the findings in X, the present study confirmed… 330 confirm if this is lame and sound legs or just one of these 331-332 remove this sentences as this wasn’t significant There seems to be a tendency for even 331 lower COPp variability in the presence of a painful limb pathology, possibly indicating a preferential 332 way of hoof loading to decrease discomfort. 337 limitations- does this journal request this to be last? Normally this is before conclusions. 341 lameness and pain free is awkward, please rephrase 346 -347 what references are these? Please cite them here and above 350 please indicate who was shod or not in the table 351 references for farriery? This seems to be appropriate to work into other aspects of the discussion 356-358 this sentence is unclear, please simplify References Journal names seem differently referenced, AJVR and others are totally spelled out while Equine Vet J is partially shortened as are others, please fix per journals standard ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-23-12780R1Evaluation of the hoof centre-of-pressure path in horses affected by chronic osteoarthritic painPLOS ONE Dear Dr. Buser, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. In particular, those related to calibration and potential effects on data and data interpretation raised and clarified by the reviewer below. Please submit your revised manuscript by Oct 05 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Aliah Faisal Shaheen Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thank you for attending to my comments on the previous version of the manuscript. The revised version is substantially improved. However, I have a few additional comments, see below. Regarding calibration of the measurement equipment, my concern for lack of validation was referring to the pressure measurement equipment. The inertial measurement unit system used for assessment of movement asymmetries I don’t have any issues with. Sorry for being unclear. Regarding calibration of the pressure measurement equipment, this is actually relevant even if you are only interested in the pressure distribution. The reason for this is that the output from the sensor isn’t linear with respect to the applied force, which means that the relative pressure distribution will be more accurate if calculated from calibrated values rather than raw voltages. This conference paper shows a graph nicely illustrating the nonlinearity of Tekscan sensors: https://isbweb.org/images/conf/2005/abstracts/0263.pdf Apart from calibration, Tekscan manual also recommends that you perform equilibration of the sensor. This is because the voltage output from each sensing element isn’t perfectly the same. In my experience, this is not a huge issue with a completely new sensor. However, with repeated use sensing elements that are subjected to high pressures become less sensitive to pressure over time. But I assume that the sensors you used were single use only? Thank you for adding the movement asymmetry values to table 1. This clarifies my question of how the subjective and objective data were combined as both lameness degree and objective data are now available in this table. The description of the first Procrustes analysis in the methods section is still unclear to me. When you compare the shape of the single-stride COPp, I assume this is comparing strides for the same limb within the same measurement sequence? Please add this in the text to avoid any confusion. Further, you describe that you compare stride 1 to stride 2 and state that “to avoid measurement errors, the Procrustes analysis was always performed between COPp recorded during 2 strides”. If you want to study within-measurement variation, then you would want to compare all pairs of strides, basically the Cartesian product. Please add a motivation why you were only interested in differences between consecutive strides (stride 1 vs 2, 2 vs 3 and so on). Maybe you’re trying to say in the sentence cited above that you anticipated that measurement errors would be more influential if comparing strides further apart (due to for example small shifts of the sensor position relative to the hoof during the trial)? The statistical analysis and the description in the statistics section are much improved from the previous version. Thank you for this. Please add whether repetition was included as a linear or as a categorical effect as both are possible/reasonable choices (depending on the data). In the results section, when reporting the results from the linear mixed model please add the estimated marginal effects in addition to the P values. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Evaluation of the hoof centre-of-pressure path in horses affected by chronic osteoarthritic pain PONE-D-23-12780R2 Dear Dr. Buser, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Aliah Faisal Shaheen Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: (No Response) ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: (No Response) ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: (No Response) ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: (No Response) ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No ********** |
| Formally Accepted |
|
PONE-D-23-12780R2 Evaluation of the hoof centre-of-pressure path in horses affected by chronic osteoarthritic pain Dear Dr. Buser: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Aliah Faisal Shaheen Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .